Cognitive Performance as a Function of MAPT Haplotype: A Prospective Longitudinal Study of an Essential Tremor Cohort
- PMID: 37214541
- PMCID: PMC10198222
- DOI: 10.5334/tohm.768
Cognitive Performance as a Function of MAPT Haplotype: A Prospective Longitudinal Study of an Essential Tremor Cohort
Abstract
Background: Cognitive impairment is a feature of essential tremor (ET). There are no studies of the genetic drivers of this association. We examined whether the microtubule-associated protein tau (MAPT) H1 haplotype is associated with cognitive performance in ET.
Methods: ET cases genotyped for the MAPT H1 and H2 haplotypes completed a battery of neuropsychological tests at baseline and four follow-up evaluations. Chi-square, t-tests, and analyses of covariance examined associations between the presence of the MAPT H1 haplotype, cognitive diagnoses of normal, mild cognitive impairment (MCI), and dementia, and performance in specific cognitive domains.
Results: We observed no evidence of cognitive differences as a function of the presence of the MAPT H1 haplotype. Specifically, cases with (n = 57) and without (n = 42) this haplotype did not differ with respect to the prevalence of diagnoses of MCI or dementia, p ≥ 0.87. Moreover, cases with vs without this haplotype did not differ in either the age or point in the disease course at which observed conversions to MCI or dementia occurred, p's ≥ 0.51. Finally, no haplotype-related differences were observed in performance in the cognitive domains of attention, executive function, language, memory, visuospatial or global ability, p's ≥ 0.21, or in changes in performance in these domains across time, p's ≥ 0.08.
Discussion: The study in an ET cohort revealed no influence of MAPT haplotypes on cognitive performance. This study serves as a valuable foundation for future studies to expand our understanding of the genetic drivers of cognitive impairment in ET.
Highlights: This study found no evidence of cognitive differences between individuals with and without the MAPT H1 haplotype. Our work provides a valuable foundation for future work to expand our knowledge of the genetic drivers of cognitive impairment in ET.
Keywords: MAPT H1; cognition; dementia; essential tremor; genetic risk factors.
Copyright: © 2023 The Author(s).
Conflict of interest statement
The authors have no competing interests to declare.
Similar articles
-
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.Brain. 2009 Nov;132(Pt 11):2958-69. doi: 10.1093/brain/awp245. Epub 2009 Oct 7. Brain. 2009. PMID: 19812213
-
The microtubule associated protein tau H1 haplotype and risk of essential tremor.Eur J Neurol. 2014 Jul;21(7):1044-8. doi: 10.1111/ene.12335. Epub 2013 Dec 26. Eur J Neurol. 2014. PMID: 24372973 Free PMC article.
-
The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.J Alzheimers Dis. 2010;22(4):1065-71. doi: 10.3233/JAD-2010-101011. J Alzheimers Dis. 2010. PMID: 20930301
-
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7. Alzheimers Dement. 2016. PMID: 27287057 Free PMC article. Review.
-
Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens.Biochem Soc Trans. 2005 Aug;33(Pt 4):582-5. doi: 10.1042/BST0330582. Biochem Soc Trans. 2005. PMID: 16042549 Review.
Cited by
-
Subjective Sleep Disturbance and Lewy Pathology: Data from a Cohort of Essential Tremor Brain Donors.Neurodegener Dis. 2024;24(1):6-15. doi: 10.1159/000539032. Epub 2024 Jun 11. Neurodegener Dis. 2024. PMID: 38861955 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical